SCHEMBL7033987

SCHEMBL7033987

CCN(CC)C(=O)C(C)(Cc1cc2ccccc2s1)C(=O)N(CC)CC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.47
ADRB2 P07550 1/20 0.44
ASIC3 Q9UHC3 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
LMNA P02545 2/20 0.42
ALOX15 P16050 2/20 0.42
ALOX12 P18054 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
AGXT P21549 1/20 0.41
ALOX5 P09917 3/20 0.40
CYP1A2 P05177 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7033990 0.93 CYP2A6 (0.44) CYP2A6ADRB2ASIC3LOXL2SLC6A2
SCHEMBL7033869 0.81 CYP2A6 (0.54) CYP2A6ADRB2ASIC3LOXL2LMNA
SCHEMBL7030160 0.80 CYP2A6 (0.53) CYP2A6ADRB2ASIC3LOXL2LMNA
SCHEMBL7025922 0.78 CYP2A6 (0.51) CYP2A6ADRB2ASIC3LOXL2LMNA
SCHEMBL7023102 0.78 CYP2A6 (0.47) CYP2A6ADRB2ASIC3LOXL2RAB9A
SCHEMBL7026250 0.77 CYP2A6 (0.54) CYP2A6ADRB2ASIC3LOXL2RAB9A
SCHEMBL28040032 0.76 CYP2A6 (0.49) CYP2A6ADRB2ASIC3LOXL2RAB9A
SCHEMBL7035382 0.76 RAB9A (0.49) CYP2A6ADRB2ASIC3LOXL2RAB9A
SCHEMBL11893281 0.75 CYP2A6 (0.58) CYP2A6ADRB2ASIC3LOXL2AGXT
SCHEMBL7029438 0.75 MMP8 (0.47) CYP2A6ADRB2ASIC3LOXL2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030109570-A1 Activate a peroxisome proliferator-activated receptor (PPAR) alpha or gamma which is an intranuclear transcription factor. The compound may be used as an active ingredient to give a drug for preventing or treating a variety of diseases MITSUI CHEMICALS, INC. (JP) 2003-06-12 US disclosed
EP-1284265-A1 BENZOTHIOPHENE DERIVATIVES AND MEDICINAL USE THEREOF Mitsui Chemicals, Inc. (JP) 2003-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109570-A1 Activate a peroxisome proliferator-activated receptor (PPAR) alpha or gamma which is an intranuclear transcription factor. The compound may be used as an active ingredient to give a drug for preventing or treating a variety of diseases PPARG, PPARA, PPARD CYP2A6 1367/4885ADRB2 792/4885ASIC3 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.